Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01265-18. Print 2019 Jan 15.
The adenovirus (Ad) serotype 5 genome encodes two noncoding small RNAs (virus-associated RNAs I and II [VA-RNAI and -II]), which are approximately 160-nucleotide (nt) RNAs transcribed by RNA polymerase III. It is well known that VA-RNAI supports Ad infection via the inhibition of double-stranded RNA-dependent protein kinase (PKR), which recognizes double-stranded RNA and acts as an antiviral system. Recent studies revealed that VA-RNAs are processed into VA-RNA-derived microRNAs (miRNAs) (mivaRNAI and -II); however, we and another group recently demonstrated that mivaRNAI does not promote Ad replication. On the other hand, the roles of VA-RNAII and mivaRNAII in Ad replication have remained to be clarified. In this study, we demonstrated mivaRNAII-mediated promotion of Ad replication. Transfection with chemically synthesized 3'-mivaRNAII-138, one of the most abundant forms of mivaRNAII, significantly enhanced Ad replication, while the other species of mivaRNAII did not. We identified 8 putative target genes of 3'-mivaRNAII-138 by microarray analysis and analysis. Among the 8 candidates, knockdown of the cullin 4A (CUL4A) gene, which encodes a component of the ubiquitin ligase complex, most significantly enhanced Ad replication. CUL4A expression was significantly suppressed by 3'-mivaRNAII-138 via posttranscriptional gene silencing, indicating that CUL4A is a target gene of 3'-mivaRNAII-138 and mivaRNAII functions as a viral miRNA promoting Ad infection. It has been reported that CUL4A is involved in degradation of c-Jun, which acts as a transcription factor in the Jun-N-terminal kinase (JNK) signaling cascade. Treatment with JNK inhibitors dramatically suppressed Ad replication, suggesting that mivaRNAII-mediated downregulation of CUL4A enhanced JNK signaling and thereby promoted Ad infection. Several types of viruses encode viral miRNAs which regulate host and/or viral gene expression via posttranscriptional gene silencing, leading to efficient viral infection. Adenovirus (Ad) expresses miRNAs derived from VA-RNAs (mivaRNAI and -II); however, recent studies have revealed that processing of VA-RNAI into mivaRNAI inhibits Ad replication. Conversely, we demonstrate here that mivaRNAII significantly promotes Ad replication and that mivaRNAII-mediated suppression of CUL4A expression via posttranscriptional gene silencing induces accumulation of c-Jun, leading to promotion of Ad infection. These results exhibited the significance of VA-RNAII for supporting Ad infection through a mechanism complementary to that of VA-RNAI. These observations could provide important clues toward a new perspective on host-virus interaction. Moreover, Ad is widely used as a basic framework for viral vectors and oncolytic viruses. Our findings will help to regulate Ad infection and will promote the development of novel Ad vectors and oncolytic Ad.
腺病毒(Ad)血清型 5 基因组编码两个非编码的小 RNA(病毒相关 RNA I 和 II [VA-RNAI 和 -II]),它们是大约 160 个核苷酸(nt)的 RNA,由 RNA 聚合酶 III 转录。众所周知,VA-RNAI 通过抑制双链 RNA 依赖性蛋白激酶(PKR)来支持 Ad 感染,PKR 识别双链 RNA 并作为抗病毒系统发挥作用。最近的研究表明,VA-RNAs 被加工成 VA-RNA 衍生的 microRNAs(miRNAs)(mivaRNAI 和 -II);然而,我们和另一个小组最近证明 mivaRNAI 并不促进 Ad 复制。另一方面,VA-RNAII 和 mivaRNAII 在 Ad 复制中的作用仍有待阐明。在这项研究中,我们证明了 mivaRNAII 介导的 Ad 复制促进作用。用化学合成的 3'-mivaRNAII-138 转染,这是 mivaRNAII 中最丰富的形式之一,显著增强了 Ad 的复制,而其他形式的 mivaRNAII 则没有。我们通过微阵列分析和 分析鉴定了 3'-mivaRNAII-138 的 8 个可能的靶基因。在 8 个候选基因中,敲低编码泛素连接酶复合物成分的 Cullin 4A(CUL4A)基因,最显著地增强了 Ad 的复制。通过 3'-mivaRNAII-138 的转录后基因沉默,CUL4A 的表达显著受到抑制,表明 CUL4A 是 3'-mivaRNAII-138 的靶基因,mivaRNAII 作为一种促进 Ad 感染的病毒 miRNA 发挥作用。据报道,CUL4A 参与 c-Jun 的降解,c-Jun 作为 JNK 信号级联中的转录因子发挥作用。JNK 抑制剂的处理显著抑制了 Ad 的复制,表明 mivaRNAII 介导的 CUL4A 下调增强了 JNK 信号,从而促进了 Ad 的感染。几种类型的病毒编码病毒 miRNA,通过转录后基因沉默调节宿主和/或病毒基因的表达,从而导致有效的病毒感染。腺病毒(Ad)表达来自 VA-RNAs(mivaRNAI 和 -II)的 miRNA;然而,最近的研究表明,VA-RNAI 的加工成 mivaRNAI 抑制了 Ad 的复制。相反,我们在这里证明 mivaRNAII 显著促进了 Ad 的复制,并且 mivaRNAII 通过转录后基因沉默抑制 CUL4A 的表达诱导 c-Jun 的积累,从而促进了 Ad 的感染。这些结果展示了 VA-RNAII 通过与 VA-RNAI 互补的机制支持 Ad 感染的重要性。这些观察结果为宿主-病毒相互作用提供了一个新的视角。此外,Ad 被广泛用作病毒载体和溶瘤病毒的基本框架。我们的发现将有助于调节 Ad 的感染,并将促进新型 Ad 载体和溶瘤 Ad 的开发。